Jane Hermansen, MT(ASCP), on What We Learned from the Promise of Theranos - Insights
Jane Hermansen, Manager, Outreach and Network Development, is featured on the cover of October’s MedicalLab Management where she takes a good look at lessons to be learned from Theranos.
In May, we wrote about the Mayo Clinic Peregrine Falcon Program's 30th anniversary. As of June 26, all three chicks have been named and have fledged. View this post to see the photos of little Generose, Epic, and Lucky Lindy.
Bobbi Pritt, M.D., Discusses Minnesota Bugs to Watch out for This Summer - Insights
In a recent article in the Star Tribune, Bobbi Pritt, M.D., Director of the Clinical Parasitology Laboratory in Mayo Clinic’s Department of Laboratory Medicine and Pathology, weighs in on bugs present in Minnesota to watch out for this...
Testing Options for Patients with Chronic Diarrhea: A Focus on Bile Acid Malabsorption - Insights
This "Specialty Testing" webinar describes a new serum test for bile acid malabsorption. Descriptions illustrate how the test can be used as a screening test and as a tool for therapeutic action.
Establishing a trusted lab partner in an evolving landscape - Insights
William Morice II, M.D., Ph.D., president and chief executive officer of Mayo Clinic Laboratories, authored a Becker’s Healthcare article on how hospital laboratories can navigate times of change and uncertainty with the steadfast support...
Guidance on subtyping of influenza A test results - Insights
Mayo Clinic Laboratories’ guidance for subtyping influenza A in response to a CDC advisory for hospitalized patients
Week in Review: March 31 - Insights
Today's Highlights Include: US FDA seeks to allow salt substitutes in everyday foods, radioactive water leaks at Minn. nuclear plant for 2nd time, and pushback grows over mental health impacts of social media.
Gadolinium-based contrast agents (GBCAs) have revolutionized MRIs by increasing the clinical utility and detection sensitivity of these exams. GBCAs also contain gadolinium, a rare earth metal with unique chemical properties. This article...
High-resolution targeted stimulant and phencyclidine (PCP) screen - Insights
In this month’s “Hot Topic,” Paul Jannetto, Ph.D., discusses the high-resolution targeted stimulant and PCP screening test from Mayo Clinic Laboratories, which offers sensitivity and specificity for use in the monitoring and management of...
NGS for Myeloid Neoplasm Evaluation - Insights
In this month's "Hot Topic," David Viswanatha, M.D., discusses updates to Mayo Clinic's next-generation sequencing (NGS) for myeloid neoplasm evaluation, involving new test targets, the rationale for new genetic regions, alignments with the...